Globe Newswire Dorothy Clarke\n\n Dorothy Clarke\n\n WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new...\n more…
Globe Newswire Final stage of technical evaluation near completion in Comera's research collaboration with Regeneron, a leading U.S. biotechnology company Expanded and strengthened Comera's global patent...\n more…
Globe Newswire WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...\n more…
Ticker Report Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA Get Free Report) was the recipient of a significant drop in short interest in August. As of August 31st, there was short interest totalling...\n more…
Globe Newswire WOBURN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...\n more…
Globe Newswire Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences ...\n more…